Introduction {#s1}
============

Cells continuously produce a large variety of proteins. To fulfill their functions, these proteins need to be properly folded, post-translationally modified, assembled into complexes and delivered to their final subcellular destinations. If errors occur in these maturation steps, compartment-specific quality control machineries clear the resulting misfolded or mislocalized proteins through refolding or degradation. These machineries are regulated by specialized adaptive responses, which adjust the folding and degradation capacity of particular organelles to ensure efficient elimination of aberrant proteins. If unresolved, protein misfolding in one compartment can disrupt overall cell homeostasis and threaten survival.

Protein maturation in the endoplasmic reticulum (ER), particularly in budding yeast, has served as a powerful paradigm to elaborate these general principles ([@bib61]; [@bib2]; [@bib3]). Newly synthesized polypeptides containing ER sorting information, for example N-terminal signal sequences, are recognized by targeting factors such as signal recognition particle (SRP) and inserted into the ER ([@bib1]). The process of protein insertion into the ER, termed translocation, is mediated by channel-forming translocon complexes ([@bib66]). Translocation additionally requires ER-lumenal chaperones such as the highly abundant Kar2, which therefore have dual roles in protein import and folding ([@bib20]; [@bib87]). Other components of the ER-resident folding machinery include oxidoreductases and glycosyltransferases ([@bib8]). Proteins that have attained their native conformation are sorted into ER-to-Golgi transport carriers. Proteins that fail to fold properly become subject to ER-associated degradation (ERAD). Key steps in ERAD are protein retrotranslocation into the cytosol with the help of the AAA ATPase Cdc48, followed by degradation by the proteasome ([@bib3]). If these mechanisms are insufficient, misfolded proteins accumulate. This condition constitutes ER stress and activates an adaptive response called the unfolded protein response (UPR) ([@bib81]). The UPR is triggered when misfolded proteins are sensed by the ER transmembrane protein Ire1. Activated Ire1 initiates non-conventional cytosolic splicing of the *HAC1* mRNA, enabling production of the transcription factor Hac1. In turn, Hac1 induces numerous genes involved in ER function ([@bib77]). The resulting increase in ER protein folding capacity resolves ER stress, closing a homeostatic feedback loop. The physiological significance of the UPR is demonstrated by yeast mutants lacking Ire1 or Hac1. When challenged by ER stress, these mutants exhibit a variety of defects in translocation, glycosylation, ERAD and ER-to-Golgi transport, and rapidly lose viability ([@bib12]; [@bib70]).

A number of UPR-independent pathways respond to, and help mitigate, ER stress. These pathways include MAP kinase signaling through Slt2/Mpk1 and Hog1, the Hsf1-dependent heat shock response and protein kinase A (PKA) signaling ([@bib5]; [@bib9]; [@bib47]; [@bib4]; [@bib34]; [@bib63]). However, exactly how they counteract ER stress has been difficult to determine. For instance, ER stress is alleviated by augmented ER-to-Golgi transport and enhanced elimination of reactive oxygen species downstream of the heat shock response and also by reduced protein synthesis downstream of PKA signaling ([@bib47]; [@bib34]; [@bib63]). Yet, these mechanisms only partially explain the beneficial effects of the signaling pathways controlling them. Finally, the UPR can, by unknown means, be amplified by Ire1-independent induction of *HAC1* transcription ([@bib45]). Therefore, it remains to be fully defined which pathways cooperate with the UPR and how they contribute to ER stress resistance.

Here, we identify the proteasome biogenesis regulator Rpn4 as an important UPR-independent factor that promotes resistance to ER stress in yeast. We show that protein misfolding induces Rpn4 activity by post-transcriptional and transcriptional mechanisms, and provide evidence that Rpn4 complements the UPR by enhancing protein quality control in the cytosol.

Results {#s2}
=======

A titratable system for the induction of ER stress {#s2-1}
--------------------------------------------------

To identify pathways cooperating with the UPR, we searched for genes that can augment resistance to ER stress in UPR-deficient cells. Mutants lacking Ire1 or Hac1 grow normally under optimal conditions but cannot proliferate under even mild ER stress ([@bib12]; [@bib70]; [@bib68]). We hypothesized that UPR mutants can be protected against ER stress by overexpression of genes that complement the UPR. If so, such genes should be identifiable through a screen based on cell growth phenotypes.

To implement this idea, we established a titratable system for the induction of ER stress. We used CPY\*, a folding-defective variant of the soluble vacuolar carboxypeptidase Y ([@bib16]). We chose an HA-tagged mutant variant of CPY\* that lacks all of its four N-glycosylation sites and is here referred to as non-glycosylatable (ng) CPY\*. After translocation into the ER, this variant is unable to fold properly and is neither efficiently cleared by ERAD nor exported to the Golgi complex ([@bib43]; [@bib71]; [@bib44]). As a result, ngCPY\* accumulates in the ER lumen and burdens the ER protein folding machinery. We placed ngCPY\* under the control of the *GAL* promoter and the artificial transcription factor Gal4-ER-Msn2 (GEM). This system allows regulation of gene expression with the exogenous steroid β-estradiol ([@bib63]). Estradiol-driven expression of ngCPY\* caused dose-dependent activation of the UPR as measured with a *HAC1* splicing reporter ([Figure 1A](#fig1){ref-type="fig"}; [@bib62]). *HAC1* splicing obtained with ≥100 nM estradiol was similar to that elicited by 0.5 µg/ml of the general ER stressor tunicamycin ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). For all estradiol concentrations tested, *HAC1* splicing declined at later time points, suggesting that cells adapted to the stress and inactivated the UPR. Estradiol-induced expression of glycosylatable CPY\*, which is degraded through ERAD and can be exported from the ER, yielded much weaker and more transient UPR activation ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Cycloheximide chase experiments confirmed that ngCPY\* was substantially more resistant to degradation than glycosylatable CPY\*, as reported ([Figure 1B](#fig1){ref-type="fig"}; [@bib43]). Furthermore, ngCPY\* tagged with superfolder GFP (sfGFP) was largely retained in the ER ([Figure 1C](#fig1){ref-type="fig"}). In contrast, CPY\*(N479Q)-sfGFP, which lacks the glycosylation site required for efficient ERAD but contains the three glycosylation sites needed for ER export, escaped to the vacuole ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}; [@bib40]).

![A titratable system for the induction of ER stress.\
(**A**) Flow cytometric measurement of GFP levels in cells harboring the *HAC1* splicing reporter and expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system. For each time point, data are normalized to untreated cells. Mean ±SEM, n = 3. (**B**) Western blot of HA and Pgk1 from cells expressing CPY\*-HA or ngCPY\*-HA. Cells were treated with cycloheximide (CHX) for the times indicated. Pgk1 served as a loading control. (**C**) Images of cells expressing ngCPY\*-sfGFP and the general ER marker Sec63-mCherry. Expression of ngCPY\*-sfGFP was induced with 25 nM estradiol for 4 hr and cells were stained with the vacuole dye CMAC. (**D**) Growth assay on solid media of wild-type (WT) and *∆hac1* cells expressing the estradiol-inducible artificial transcription factor GEM and, where indicated, ngCPY\* under the control of the *GAL* promoter. For each strain, series represent fivefold dilution steps. (**E**) Growth assay in liquid media of WT cells expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system. a.u., arbitrary units. (**F**) As in panel E, but with *∆hac1* cells.](elife-43244-fig1){#fig1}

Estradiol did not affect growth of wild-type or *∆hac1* cells expressing only the artificial transcription factor GEM ([Figure 1D](#fig1){ref-type="fig"}). Furthermore, estradiol-induced expression of ngCPY\* in wild-type cells caused only modest growth defects on solid media, even at the highest estradiol concentration tested. In *∆hac1* cells, however, induction of ngCPY\* expression with increasing concentrations of estradiol strongly retarded and eventually prevented cell proliferation. Growth assays in liquid media yielded similar results ([Figure 1E and F](#fig1){ref-type="fig"}). To determine whether the lack of proliferation of *∆hac1* cells reflected a growth arrest or cell death, we assayed cell viability after expression of ngCPY\*. No loss of viability of *∆hac1* cells occurred, even with estradiol concentrations that completely blocked proliferation ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). Hence, expression of ngCPY\* merely caused a growth arrest. In summary, this estradiol-controlled system can be titrated to induce defined levels of ER stress and can be used to prevent growth of UPR-deficient cells.

A screen for genes promoting ER stress resistance in UPR mutants {#s2-2}
----------------------------------------------------------------

We exploited the ngCPY\*-induced growth arrest in UPR mutants to conduct a multicopy suppression screen. Cells lacking *HAC1* and containing the titratable ER stress system were transformed with a genomic library in a high-copy vector. Transformants were first allowed to form colonies on estradiol-free solid medium and then replicated onto media containing a range of estradiol concentrations sufficient to block growth of the parental strain. Plasmids were retrieved from transformants able to grow on estradiol-containing plates and their inserts were sequenced. The obtained candidate genes were individually subcloned into the same high-copy vector and tested for their ability to suppress the toxicity of ngCPY\* in *∆hac1* cells.

As expected, the strongest suppressor was *HAC1*, which complemented the *HAC1* deletion in the parental strain. The next strongest suppressors as judged by growth assays on solid and in liquid media were *RPN4*, *PDR1* and *SSZ1*. Additional, but weaker, suppressors were *YAP1*, *CAD1*, *SAF1*, *MUM2* and *NOP56* ([Table 1](#table1){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}). Rpn4 is a transcription factor that localizes to the cytosol and the nucleus ([@bib76]). Its primary function is the induction of genes encoding proteasome subunits ([@bib15]). Pdr1 is another transcription factor, controls genes involved in multidrug resistance and induces *RPN4* transcription ([@bib60]; [@bib64]). Ssz1 is part of the ribosome-associated chaperone complex and its overproduction activates Pdr1 ([@bib26]; [@bib11]). Yap1 is a third transcription factor, mediates the oxidative stress response and also induces *RPN4* transcription ([@bib60]). Considering these links, we tested whether Pdr1, Ssz1 and Yap1 enhanced ER stress resistance by raising Rpn4 levels. We generated *∆hac1* cells in which the *RPN4* gene was controlled by the constitutive *CYC1* promoter and thus uncoupled from its normal regulation. We then overexpressed *RPN4*, *PDR1*, *SSZ1* or *YAP1* and assayed growth in the presence ngCPY\*. Overexpression of all four genes promoted growth under these conditions ([Figure 3A](#fig3){ref-type="fig"}). Hence, Pdr1, Ssz1 and Yap1 can enhance ER stress resistance also when they are unable to activate the *RPN4* promoter. It therefore appears likely that Pdr1 and Yap1 relieve ER stress in our system by inducing target genes other than *RPN4*. In the case of Pdr1, candidates include genes for multidrug transporters such as *PDR5*, *PDR10* and *PDR15*, which may export estradiol from cells and thereby lower the levels of ngCPY\*.

![Multicopy suppression of ngCPY\* toxicity in *∆hac1* cells.\
(**A**) Growth assay on solid media of wild-type (WT) and *∆hac1* cells expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system and overexpressing *RPN4*, *SSZ1* or *PDR1* from extrachromosomal plasmids where indicated. (**B**) Growth assay in liquid medium of WT and *∆hac1* cells expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system. *∆hac1* cells additionally overexpressed the indicated genes. Cells were grown without estradiol. a.u., arbitrary units. (**C**) As in panel B, but in the presence of 50 nM estradiol. (**D**) Quantification of growth assays as shown in panel B. Data are normalized to WT cells. Mean ±SEM, n = 4. (**E**) Quantification of growth assays as shown in panel C. Data are normalized to WT cells. Mean ±SEM, n = 4.](elife-43244-fig2){#fig2}

![Rpn4 and the UPR are functionally linked.\
(**A**) Growth assay on solid media of *∆hac1* cells containing the constitutive *CYC1* promoter in place of the endogenous *RPN4* promoter, expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system and overexpressing *RPN4*, *SSZ1*, *PDR1* or *YAP1* where indicated. (**B**) Growth assay on solid media of wild-type (WT), *∆rpn4*, *∆hac1* and *∆hac1 ∆rpn4* cells expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system and overexpressing *RPN4* where indicated. (**C**) As in panel B, but on media containing different concentrations of tunicamycin (Tm).](elife-43244-fig3){#fig3}
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###### Genes identified in the screen.

  Gene      Description
  --------- ---------------------------------------------------------------------------------------------
  *HAC1*    transcription factor, regulates the unfolded protein response
  *RPN4*    transcription factor, stimulates expression of proteasome genes
  *PDR1*    transcription factor, regulates the pleiotropic drug response, induces *RPN4* transcription
  *SSZ1*    Hsp70 chaperone, part of ribosome-associated complex, overexpression activates Pdr1
  *MUM2*    protein essential for meiotic DNA replication and sporulation
  *YAP1*    transcription factor, regulates response to oxidative stress, induces *RPN4* transcription
  *CAD1*    transcription factor, involved in stress responses, paralog of *YAP1*
  *SAF1*    F-box protein, subunit of SCF ubiquitin ligase complexes
  *NOP56*   essential nucleolar protein

The identification of Rpn4 suggests that enhanced proteasome biogenesis promotes ER stress resistance. However, the entirety of genes controlled by Rpn4, here referred to as the Rpn4 regulon, encompasses many genes beyond those encoding proteasome subunits ([@bib49]; [@bib38]). Rpn4 may therefore counteract ER stress by more than one mechanism. Indeed, the *RPN4* regulator Yap1 is itself activated by Rpn4 ([@bib49]) and may aid stress resistance by preventing oxidative damage. Furthermore, we directly tested the Rpn4 target gene *CDC48* ([@bib7]), even though it was not found in the screen. Overexpression of *CDC48* also restored growth of *∆hac1* cells expressing ngCPY\*, although weakly compared to overexpression of *RPN4* ([Figure 2B-E](#fig2){ref-type="fig"}). Overall, the outcome of the screen suggests that Rpn4 activity becomes limiting for cell proliferation during ER stress, at least in UPR mutants.

Rpn4 and the UPR cooperate to counteract ER stress {#s2-3}
--------------------------------------------------

*RPN4* is not controlled by Hac1 and hence not a UPR target gene ([@bib77]; [@bib63]). This lack of a direct link suggests that Rpn4 acts in parallel to, rather than downstream of, the UPR ([@bib57]). To better understand the interplay between Rpn4 and the UPR, we manipulated Rpn4 levels in wild-type and ∆*hac1* cells and challenged these cells with ngCPY\* or tunicamycin ([Figure 3B and C](#fig3){ref-type="fig"}). Overexpression of *RPN4* in wild-type cells increased resistance to both stressors. This observation indicates that Rpn4 activity becomes limiting for cell proliferation during ER stress also when the UPR is intact. Conversely, deletion of *RPN4* caused a general growth defect and sensitized cells to ngCPY\* and tunicamycin, consistent with previous reports ([@bib82]; [@bib34]; [@bib67]). As expected, *∆hac1* cells were highly vulnerable to either ER stressor, and *RPN4* overexpression provided a measure of protection. *∆hac1 ∆rpn4* cells grew very poorly already in the absence of ngCPY\* or tunicamycin, and not at all in their presence. The synthetic sickness phenotype of *∆hac1 ∆rpn4* cells agrees with earlier reports and shows that Rpn4 and the UPR are functionally linked ([@bib57]; [@bib34]).

The slow growth of *∆hac1 ∆rpn4* double mutants compared with *∆rpn4* single mutants implies that the UPR is constitutively active and physiologically important in Rpn4-deficient cells. Indeed, *HAC1* splicing was elevated in untreated *∆rpn4* cells, consistent with high throughput data ([Figure 4A](#fig4){ref-type="fig"}; [@bib39]). Accordingly, quantitative real-time PCR showed that mRNA levels of the UPR target genes *KAR2* and *SIL1* were higher in *∆rpn4* mutants than in wild-type cells ([Figure 4B and C](#fig4){ref-type="fig"}). To further characterize the effect of *RPN4* deletion, we compared the proteomes of wild-type and *∆rpn4* cells by quantitative mass spectrometry. As expected, the abundance of proteasome subunits was reduced in cells lacking Rpn4, while the abundance of proteins encoded by UPR target genes was increased ([Figure 4D](#fig4){ref-type="fig"} and [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}). Many other proteins were changed significantly, illustrating the profound impact of loss of Rpn4. First, Cdc48 levels were lower in *∆rpn4* cells. Second, the levels of the stress-inducible proteasome assembly chaperone Tma17 and its activator Slt2/Mpk1 were elevated ([@bib28]; [@bib67]). Third, cytosolic protein folding machinery was upregulated and the abundance of many ribosomal proteins was suppressed, indicating a broad stress response ([@bib19]). Fourth, many proteins that are involved in sterol synthesis and constitutively turned over by different ERAD pathways were more abundant in *∆rpn4* cells. These proteins included Erg1, 3, 5, 9, 11, 25, 27, 28 and Hmg2, although only Erg1 and Erg3 met our stringent criteria for significance ([@bib27]; [@bib17]; [@bib18]; [@bib32]; [@bib41]; [@bib10]). Their accumulation implies generally impaired ERAD in *∆rpn4* cells. Importantly, neither Erg1 nor Erg3 are regulated by the UPR ([@bib77]; [@bib63]), arguing against the possibility that their increased abundance can be explained by the constitutive activation of the UPR in *∆rpn4* cells. In sum, cells lacking Rpn4 suffer from chronic ER stress, likely because inefficient ERAD leads to an accumulation of misfolded and redundant proteins in the ER. In response, they activate the UPR, augment proteasome assembly capacity, enhance cytosolic protein folding and attenuate protein synthesis.

![Loss of Rpn4 activates the UPR and triggers a broad adaptive response.\
(**A**) Flow cytometric measurement of GFP levels relative to cytosolic BFP in wild-type (WT) and *∆rpn4* cells harboring the *HAC1* splicing reporter. Data are normalized to WT cells. Mean ±SEM, n = 3. (**B**) *KAR2* mRNA levels in WT and *∆rpn4* cells as measured by quantitative real-time PCR. Data are normalized to WT cells. Mean ±SEM, n = 3. (**C**) As in panel B, but for *SIL1*. (**D**) Global effects of *RPN4* deletion on protein expression. For each protein, the x axis shows the average log~2~ fold change between WT and *∆rpn4* cells (proteins increased in the *∆rpn4* strain have positive values); the y axis shows the result of a t test for that difference (two-tailed; n = 4). The ''volcano'' lines indicate thresholds of significance. Proteins falling above the volcano lines are significantly changed. The left and right panels show the same plot but with different proteins highlighted. See [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"} for the data used to generate the plot. In *∆rnp4* cells, proteasome subunits are downregulated (blue dots, p=1.1×10^−17^, n = 32), UPR targets are upregulated (red dots, p=1.8×10^−9^, n = 50), ribosomal proteins are downregulated (green dots, p=7.5×10^−29^, n = 89) and proteins involved in cytosolic protein folding are upregulated (yellow dots, p=3.8×10^−9^, n = 14).\
10.7554/eLife.43244.008Figure 4---source data 1.Proteomics data.](elife-43244-fig4){#fig4}

The above results show that cells attempt to compensate the lack of Rpn4 by activating the UPR. To test whether the inverse is true and cells compensate the lack of a functionally sufficient UPR by activating the Rpn4 regulon, we monitored Rpn4 abundance. Rpn4 is a short-lived protein that is rapidly turned over by the proteasome ([@bib85]). When proteasome capacity becomes limiting, Rpn4 accumulates and promotes proteasome biogenesis until its degradation is restored. This negative feedback loop homeostatically adjusts proteasome activity ([@bib15]). The levels of chromosomally tagged Rpn4-HA in wild-type and *∆hac1* cells were similar at steady state ([Figure 5A and B](#fig5){ref-type="fig"}). Upon treatment with 2 µg/ml tunicamycin, they increased two-fold within 15 min. Subsequently, Rpn4 abundance continued to climb but did so more quickly in *∆hac1* cells, reaching more than four-fold basal levels after 60 min. To determine whether this rise involved an upregulation of *RPN4* transcription, we analyzed *RPN4* mRNA by quantitative real-time PCR. In wild-type cells, tunicamycin treatment for up to 60 min induced the UPR target genes *KAR2* and *SIL1* ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), but not *RPN4* ([Figure 5D](#fig5){ref-type="fig"}). Therefore, under these conditions, Rpn4 accumulates through a post-transcriptional mechanism, presumably by slowed degradation. In *∆hac1* cells, tunicamycin treatment induced *KAR2* and *SIL1* less strongly than in wild-type cells but increased *RPN4* mRNA levels. While we cannot rule out changes in mRNA stability, we assume that this rise reflects enhanced transcription. This response likely contributes to the more pronounced stress-induced upregulation of Rpn4 abundance in *∆hac1* cells. Importantly, prolonged ER stress upon treatment with 5 µg/ml tunicamycin raised *RPN4* mRNA levels also in wild-type cells ([Figure 5E](#fig5){ref-type="fig"}). Accordingly, the protein abundance of proteasome subunits and all detectable proteasome assembly chaperones was elevated ([Figure 5F](#fig5){ref-type="fig"} and [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}). Hence, during ER stress, cells augment the UPR by enhancing Rpn4 activity and promoting proteasome biogenesis. Interestingly, proteasome subunit abundance still increased during ER stress in *∆rpn4* cells ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), possibly reflecting a recently suggested post-transcriptional mechanism mediated by Slt2/Mpk1 ([@bib67]). Nevertheless, the levels of proteasome subunits in ER-stressed *∆rpn4* cells remained below even those of untreated wild-type cells. Collectively, these results show that activation of the UPR and the Rpn4 regulon are two cooperating elements of the cellular response to ER stress.

![ER stress increases Rpn4 abundance, induces *RPN4* transcription and promotes proteasome biogenesis.\
(**A**) Western blot of HA and Pgk1 from wild-type (WT) and *∆hac1* cells expressing Rpn4-HA and treated with 2 µg/ml tunicamycin (Tm) for the times indicated. (**B**) Quantification of Rpn4-HA protein levels relative to Pgk1 from western blots as shown in panel A. Data are normalized to WT cells at t = 0. Mean ±SEM, n = 5. (**C**) *KAR2* mRNA levels in WT and *∆hac1* cells treated with 2 µg/ml tunicamycin for the times indicated. Data are normalized to WT cells at t = 0. Mean ±SEM, n = 3. (**D**) As in panel C, but for *RPN4*. (**E**) As in panel C, but for *RPN4* after treatment with 5 µg/ml tunicamycin for the times indicated. (**F**) Global effects of tunicamycin treatment on protein expression. For each protein, the x axis shows the average log~2~ fold change between untreated WT cells and WT cells treated with 5 µg/ml tunicamycin for 4 hr (proteins upregulated by the treatment have positive values); the y axis shows the result of a t test for that difference (two-tailed; n = 4). The ''volcano'' lines indicate thresholds of significance. Proteins falling above the volcano lines are significantly changed. See [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"} for the data used to generate the plot. Treatment with tunicamycin causes upregulation of proteasome subunits (dark blue dots, p=7.6×10^−3^, n = 32), proteasome assembly chaperones (light blue dots, p=3.3×10^−3^, n = 8), and UPR targets (red dots, p=3.3×10^−22^, n = 58).](elife-43244-fig5){#fig5}

Rpn4 is upregulated by and protects against mislocalized secretory proteins {#s2-4}
---------------------------------------------------------------------------

We next asked how ER stress upregulates Rpn4. The stronger increase in Rpn4 abundance and the more sensitive *RPN4* transcriptional response in *∆hac1* cells may reflect more severe ER stress in these mutants. To test this assumption, we used protein translocation as readout for ER function. When the capacity of ER chaperones is exhausted, they can no longer assist protein import. As a result, translocation is compromised, including that of Kar2 itself ([@bib80]). Western blotting showed a single band for Kar2 in untreated wild-type and *∆hac1* cells ([Figure 6A](#fig6){ref-type="fig"}). Treatment with 2 µg/ml tunicamycin for up to 60 min did not change Kar2 levels. However, a second Kar2 band of slightly higher molecular weight appeared in *∆hac1* cells, starting at 30 min. Since Kar2 is not glycosylated, this upshift indicates retention of its cleavable signal sequence (ss) and suggests that the slower migrating form corresponds to untranslocated ss-Kar2 ([@bib56]). Hence, under these conditions, *∆hac1* cells show signs of overwhelmed chaperone capacity. Treatment with 5 µg/ml tunicamycin increased Kar2 abundance in wild-type cells and caused the appearance of ss-Kar2 in both strains ([Figure 6B](#fig6){ref-type="fig"}). Therefore, strong ER stress impairs translocation also in wild-type cells. These results confirm that ER stress is initially buffered by the UPR in wild-type cells but rapidly disrupts ER function in *∆hac1* cells.

![*RPN4* is upregulated by cytosolic mislocalization of secretory proteins.\
(**A**) Western blot of Kar2 and Pgk1 from wild-type (WT) and *∆hac1* cells treated with 2 µg/ml tunicamycin for the times indicated. The asterisk indicates untranslocated ss-Kar2. (**B**) As in panel A, but with 5 µg/ml tunicamycin. (**C**) Western blot of Kar2 and Pgk1 from *sec65-1* cells grown at 25°C and shifted to the indicated temperatures for 90 min. The asterisk indicates untranslocated ss-Kar2. (**D**) *RPN4* mRNA levels in WT and *sec65-1* cells grown at 25°C and shifted to the indicated temperatures for 90 min. Data are normalized to WT cells at 25°C. Mean ±SEM, n = 3. (**E**) Flow cytometric measurement of GFP levels in WT and *sec65-1* cells harboring the *HAC1* splicing reporter. Cells grown at 25°C were shifted to the indicated temperatures or treated with 2 µg/ml tunicamycin (Tm) for 90 min. For each strain, data are normalized to 25°C. Mean ±SEM, n = 3.](elife-43244-fig6){#fig6}

The above results reveal a conspicuous correlation between impaired translocation and elevated *RPN4* mRNA levels. Both phenomena occur in *∆hac1* cells exposed to 2 µg/ml tunicamycin, whereas 5 µg/ml are required in wild-type cells. Impaired translocation and increased *RPN4* mRNA levels could be unrelated consequences of ER stress. Alternatively, their correlation could reflect a causal relationship, with translocation defects activating *RPN4* transcription. To distinguish between these possibilities, we employed *sec65-1* cells, which express a temperature-sensitive variant of the SRP subunit Sec65 ([@bib74]). Disruption of SRP function rapidly inhibits translocation and causes accumulation of secretory proteins in the cytosol, where they are unable to fold properly. As expected, Kar2 translocation was intact in *sec65-1* cells at the permissive temperature of 25°C but impaired upon a shift to 30°C or above ([Figure 6C](#fig6){ref-type="fig"}; [@bib56]). *RPN4* mRNA levels did not change when wild-type or *sec65-1* cells were shifted from 25°C to 28°C ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). However, shifts to temperatures of 30°C or above raised *RPN4* mRNA levels specifically in *sec65-1* cells ([Figure 6D](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Importantly, *HAC1* splicing was not activated under these conditions ([Figure 6E](#fig6){ref-type="fig"}). Therefore, disrupted translocation induces the *RPN4* gene even in the absence of ER stress. This finding indicates that stress-induced translocation defects activate *RPN4* transcription.

To examine the physiological significance of *RPN4* expression in cells suffering from translocation defects, we analyzed growth of *sec65-1* cells at different temperatures. Cells grew normally at up to 28°C but showed almost no growth at 30°C or above ([Figure 7A](#fig7){ref-type="fig"}). These observations are consistent with the described tight temperature sensitivity of the *sec65-1* allele ([@bib74]). *RPN4* overexpression restored some growth at 30°C and 32°C, showing that the levels of Rpn4 were physiologically important under these conditions. Next, we tested whether elevated Rpn4 abundance promoted the degradation of misfolded cytosolic proteins. Cycloheximide chase experiments showed that *RPN4* overexpression accelerated the degradation of ∆ss-ngCPY\*-HA, which mislocalizes to the cytosol due to deletion of its signal sequence ([Figure 7B and C](#fig7){ref-type="fig"}). The same was true for Luciferase(DM)-mCherry, another misfolded cytosolic model protein ([Figure 7D](#fig7){ref-type="fig"}). Collectively, these experiments indicate that the Rpn4 regulon is activated by and protects against cytosolic mislocalization of secretory proteins.

![Rpn4 protects against cytosolic protein misfolding.\
(**A**) Growth assay on solid medium of *sec65-1* cells grown at different temperatures and overexpressing *RPN4* where indicated. (**B**) Western blot of HA and Pgk1 from cycloheximide-treated wild-type (WT) cells expressing ∆ss-ngCPY\*-HA and additionally overexpressing *RPN4* where indicated. Expression of ∆ss-ngCPY\*-HA was induced with 100 nM estradiol for 4 hr. The asterisk indicates a slower-migrating, post-translationally modified form of ∆ss-ngCPY\*-HA. CHX, cycloheximide. (**C**) Quantification of ∆ss-ngCPY\*-HA levels relative to Pgk1 from western blots as shown in panel B. For each strain, data are normalized to t = 0. Mean ±SEM, n = 3. (**D**) Luciferase(DM)-mCherry levels relative to Pgk1 and normalized to t = 0. Quantification is based on western blots of mCherry and Pgk1 from cycloheximide-treated cells expressing Luciferase(DM)-mCherry and additionally overexpressing *RPN4* where indicated. Mean ±SEM, n = 3. (**E**) Flow cytometric measurement of GFP levels in *∆hac1* cells harboring the *HAC1* splicing reporter (HAC1-SR), HSE reporter or HSP12 reporter, expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system, and overexpressing *RPN4* where indicated. Expression of ngCPY\* was induced with 100 nM estradiol for 5 hr. Data are normalized to cells not treated with estradiol. Mean ±SEM, n = 3.](elife-43244-fig7){#fig7}

Our results show that *RPN4* overexpression protects against ER stressors and cytosolically mislocalized secretory proteins, suggesting that it counteracts folding stress in the ER and the cytosol. To test this notion, we used reporters for three different stress response pathways: the *HAC1* splicing reporter for the UPR, a heat shock element (HSE) reporter for the Hsf1-dependent heat shock response ([@bib88]) and an *HSP12* reporter for the Msn2/4-dependent general stress response ([@bib63]). The transcription factors Msn2 and Msn4 are kept inactive by PKA ([@bib22]). Stress conditions inhibit PKA, resulting in derepression of Msn2/4 and induction of genes such as *HSP12* ([@bib63]). Although Hsf1 and the PKA-Msn2/4 pathway respond to prolonged ER stress ([@bib47]; [@bib63]), they monitor the folding environment in the cytosol, and we employed the *HSE* and *HSP12* reporters to read out cytosolic protein homeostasis. We introduced the reporters into *∆hac1* cells that did or did not overexpress *RPN4*, induced ER stress by ngCPY\* expression and determined reporter activity. Expression of ngCPY\* activated all three reporters, which was attenuated by *RPN4* overexpression ([Figure 7E](#fig7){ref-type="fig"}). This result shows that Rpn4 can indeed improve protein homeostasis in both the ER and the cytosol.

Multiple signaling pathways mediate *RPN4* induction by ER stress {#s2-5}
-----------------------------------------------------------------

Finally, we investigated through which signaling pathways ER stress induces the *RPN4* gene. The *RPN4* promoter contains well-characterized binding sites for Pdr1/3, Yap1 and Hsf1, called the Pdr1/3 response element (PDRE), Yap1 response element (YRE) and heat shock element (HSE), respectively ([@bib60]; [@bib24]). To test the relevance of these binding sites, we generated *RPN4* reporters in which different *RPN4* promoter variants controlled expression of the fast-maturing fluorescent protein mNeonGreen and measured mNeonGreen levels by flow cytometry. Steady-state activity of the *RPN4* reporter was essentially unchanged by mutation of the two PDREs or the YRE but was reduced by 40% upon mutation of the HSE ([Figure 8A](#fig8){ref-type="fig"}). Tunicamycin treatment activated the *RPN4* reporter, which was unaffected by mutation of any of the above promoter elements ([Figure 8B](#fig8){ref-type="fig"}). Hence, Hsf1 regulates basal *RPN4* activity, but Pdr1/3, Yap1 and Hsf1 appear to be individually dispensable for *RPN4* induction by ER stress.

![Multiple signaling pathways mediate *RPN4* induction by ER stress.\
(**A**) Flow cytometric measurement of the activity of *RPN4* reporter variants in untreated cells. Data are normalized to the reporter containing the native *RPN4* promoter. The other reporters contain mutations in the two Pdr1/3 response elements (PDREm), the Yap1 response element (YREm) or the heat shock element (HSEm). Mean ±SEM, n = 4. (**B**) As in panel A, but after treatment with 5 µg/ml tunicamycin for the times indicated. Mean ±SEM, n = 3. (**C**) Flow cytometric measurement of the activity of the native *RPN4* reporter in *tpk1/2/3-as* and *tpk1/2/3 ∆msn2/4* cells treated with the ATP analog 1NM-PP1 for the times indicated. The analog-sensitive *tpk1/2/3-as* alleles enable specific inhibition of protein kinase A with 1NM-PP1. Mean ±SEM, n = 3. (**D**) *RPN4* mRNA levels in wild-type (WT) and *tpk1/2/3-as* cells treated with 1NM-PP1 for the times indicated. Data are normalized to WT cells at t = 0. Mean ±SEM, n = 3. (**E**) Flow cytometric measurement of the activity of *RPN4* reporter variants in WT and *∆msn2/4* cells treated with 5 µg/ml tunicamycin. Data are normalized to WT cells containing the reporter with the native *RPN4* promoter. Mean ±SEM, n = 3. (**F**) Model for the cooperation of Rpn4 and the UPR. ER protein misfolding causes increased flux through the ERAD pathway, which strains proteasome capacity and inhibits efficient protein degradation (1). In addition, the UPR is activated (2). Severe ER stress leads to translocation defects, causing mislocalization of secretory proteins to the cytosol, where they cannot fold properly (3). These cytosolic misfolded proteins further burden the proteasome (4). As a result, Rpn4 is stabilized, the Rpn4 regulon is activated and proteasome biogenesis is enhanced. If cytosolic misfolded proteins persist, the *RPN4* gene is induced (5), providing a second mechanism to increase Rpn4 abundance and augment proteasome biogenesis.](elife-43244-fig8){#fig8}

Given that ER stress triggers the general stress response ([@bib63]), we asked whether Msn2/4 downstream of PKA can activate the *RPN4* gene. We used a strain in which the PKA isoforms Tpk1/2/3 had been modified such that their enlarged ATP binding pockets allowed specific inhibition of these kinases with the bulky ATP analog 1NM-PP1 ([@bib29]). 1NM-PP1 treatment of cells harboring the analog-sensitive *tpk1/2/3-as* alleles induced both the *RPN4* reporter and the endogenous *RPN4* gene ([Figure 8C and D](#fig8){ref-type="fig"}). As expected, deletion of *MSN2/4* strongly reduced activation of the *RPN4* reporter upon PKA inhibition ([Figure 8C](#fig8){ref-type="fig"}). Activation of the *RPN4* reporter by tunicamycin was blunted in *∆msn2/4* cells but not blocked ([Figure 8E](#fig8){ref-type="fig"}), suggesting that prolonged ER stress activates partially redundant mechanisms to induce *RPN4*. Accordingly, combined deletion of *MSN2/4* and mutation of the YRE or the HSE additively reduced activation of the *RPN4* reporter. Mutation of both the YRE and the HSE almost completely abolished reporter activation in a *∆msn2/4* background. These results show that multiple signaling pathways contribute to the induction of *RPN4* transcription by ER stress.

Discussion {#s3}
==========

We have shown that Rpn4 and the UPR cooperate to counteract ER stress. Based on our findings, we propose the following model ([Figure 8F](#fig8){ref-type="fig"}). Protein misfolding in the ER burdens the proteasome by increased flux through the ERAD pathway, activates the UPR and eventually impairs protein translocation into the ER. As a result, secretory proteins mislocalize to the cytosol, where they are unable to fold properly and further strain proteasome capacity. Inefficient proteasomal degradation leads to an increase in Rpn4 abundance and activation of the Rpn4 regulon, which enhances proteasome biogenesis to clear misfolded ER and cytosolic proteins. Furthermore, persistent cytosolic protein misfolding induces the *RPN4* gene through the transcription factors Msn2/4, Yap1 and Hsf1. The resulting rise in Rpn4 protein levels reinforces activation of the Rpn4 regulon.

Rpn4 abundance is controlled by rapid proteasomal turnover ([@bib85]) and by *RPN4* gene activity. ER stress initially increases Rpn4 protein levels. Persistent ER stress, however, additionally raises *RPN4* mRNA levels. These observations suggest a biphasic Rpn4 response. First, when misfolded proteins occupy the proteasome, Rpn4 is spared from degradation and activates its target genes, but *RPN4* transcription remains unchanged. This scenario likely applies to early phases of ER stress and cases of mild stress. For instance, expression of the misfolded ER membrane protein Ste6\* activates the Rpn4 regulon but not *RPN4* transcription ([@bib52]). If slowed Rpn4 degradation is insufficient to resolve the stress, *RPN4* transcription is upregulated in a second phase of the response, which provides another boost in Rpn4 target gene induction. Msn2/4, Yap1 and Hsf1 contribute to the stress-induced upregulation of *RPN4*, indicating that parallel pathways communicate protein misfolding to the *RPN4* promoter. This situation is distinct from *RPN4* induction after glucose starvation or heat shock, which requires Hsf1 but not Msn2/4 ([@bib25]). Interestingly, the *RPN4* promoter does not contain a canonical stress response element as binding site for Msn2/4 ([@bib50]). Therefore, it is not clear whether Msn2/4 bind to the *RPN4* promoter directly, although high throughput data hint at this possibility ([@bib30]; [@bib35]). Furthermore, it remains to be determined exactly how cytosolic misfolding is sensed by Msn2/4, Hsf1 and Yap1. While the detection of misfolded cytosolic proteins by Hsf1 has been studied extensively, it is unknown how protein kinase A, which controls Msn2/4 and possibly also Hsf1 ([@bib79]), may monitor protein folding. Finally, it is unclear whether Yap1 is directly activated by misfolded proteins. Alternatively, its contribution to *RPN4* activation could reflect the fact that *YAP1* is an Rpn4 target gene ([@bib49]) and may reinforce *RPN4* transcription as part of a positive feedback loop.

Rpn4 controls genes involved in many processes, including proteasome biogenesis, protein ubiquitination and DNA repair ([@bib49]; [@bib38]). Hence, the Rpn4 regulon could increase ER stress resistance through a combination of functional outputs. However, it has been shown that the sensitivity of *∆rpn4* cells to various stresses, including ER stress, results from their impaired induction of proteasome genes ([@bib82]). Enhanced proteasome biogenesis is therefore likely to be critical for the promotion of ER stress resistance by Rpn4. Accordingly, overexpression of the Rpn4 target genes *YAP1* or *CDC48* increases ER stress resistance of UPR mutants much more weakly than *RPN4* overexpression. Therefore, the relevant functions of Rpn4 must extend beyond inducing Yap1-driven oxidative stress tolerance or Cdc48-dependent ERAD, and our data support the notion that enhancing degradation of cytosolically mislocalized secretory proteins is a major factor. Nevertheless, the relative contributions of different components of the Rpn4 regulon to ER stress resistance remain to be delineated.

An effective UPR requires sufficient proteasome capacity to remove misfolded proteins through ERAD. Yet, the UPR does not control genes encoding proteasome subunits ([@bib77]). Furthermore, the only proteasome-related genes among the 102 genes we defined as core UPR targets were *PBA1* and *ADD66*, which encode proteasome assembly chaperones. Conversely, the Rpn4 regulon comprises most genes for proteasome subunits but only a few genes involved in ER protein folding, such as *PDI1* ([@bib49]). Hence, the transcriptional programs activated by the UPR and Rpn4 are largely distinct. They are, however, functionally complementary and represent two cooperating modules. This functional complementarity explains the strong negative genetic interaction between *HAC1* and *RPN4*. Remarkably, ER stress activates a second signaling pathway that promotes proteasome biogenesis. The Slt2/Mpk1 MAP kinase, which augments ER stress resistance, controls chaperones responsible for 19S regulatory particle assembly and increases the abundance of complete 26S proteasomes during stress ([@bib5]; [@bib9]; [@bib67]). Taken together, it is evident that proteasome biogenesis is an important UPR-independent process that enhances resistance to ER stress.

ER homeostasis and proteasome biogenesis are coupled also in higher eukaryotes, as shown by activation of the mammalian UPR upon proteasome inhibition ([@bib58]; [@bib59]). Furthermore, the mechanisms adjusting proteasome abundance in yeast and mammals share extensive similarities. Proteasome inhibition, which mimics proteasome overload, induces proteasome genes also in mammalian cells ([@bib53]; [@bib51]). This response is mediated by the transcription factor Nrf1 and the Slt2/Mpk1 homolog Erk5 ([@bib65]; [@bib73]; [@bib67]). Similar to Rpn4, Nrf1 is short-lived and activates many proteasome genes ([@bib65]; [@bib73]). Remarkably, Nrf1 is constitutively turned over by ERAD ([@bib73]). Hence, when ER stress overburdens ERAD, Nrf1 is stabilized and can promote proteasome biogenesis. Another intriguing parallel involves the mammalian proteasome assembly chaperones PAC1/2. As mentioned above, expression of their yeast counterparts *PBA1* and *ADD66* is induced by the UPR. PAC1/2 protein abundance also increases during ER stress, although this is achieved by iRhom1-mediated stabilization ([@bib46]). Understanding the links between the UPR and proteasome biogenesis is relevant for human disease. Multiple myeloma cells suffer from chronic ER stress and are highly sensitive to proteasome inhibition, implying that proteasome capacity is limiting for survival of these cells. This insight has led to major improvements in the treatment of plasma cell cancer through the use of proteasome inhibitors ([@bib21]).

A simple perspective on adaptive responses is that protein misfolding in a particular subcellular compartment triggers a dedicated program that enhances quality control specifically in the troubled organelle. Our work supports a more holistic view that emphasizes two additional concepts: functional modularity and cross-compartment coordination. Regulated proteasome biogenesis is a functional module that serves as part of the cellular response to ER stress. Interestingly, proteasome biogenesis is also activated by impaired mitochondrial protein import ([@bib84]; [@bib83]; [@bib6]). It may therefore be a functional module that is commonly employed when stress necessitates clearance of mislocalized proteins from the cytosol. Autophagy and global attenuation of translation may be other such modules ([@bib19]). Furthermore, adaptive responses are not restricted to the compartment where stress initially arises. For example, as shown here, ER stress activates the UPR but also the Rpn4 regulon to safeguard against protein misfolding in the cytosol. Second, certain types of mitochondrial stress trigger the mitochondrial unfolded protein response but also activate the cytosolic heat shock response and promote proteasome biogenesis ([@bib33]; [@bib84]; [@bib42]; [@bib6]). Third, cytosolic folding stress activates the Hsf1-dependent heat shock response, which promotes protein folding in the cytosol but also controls the expression of major chaperones that function elsewhere, including Kar2 in the ER and Ssc1 in mitochondria ([@bib86]; [@bib23]). Fourth, the UPR regulates genes that function in the entire secretory pathway ([@bib77]). Many additional links between different organelle quality control systems exist in yeast and higher eukaryotes ([@bib31]). A driving force for the evolution of these links may have been the need to prevent the spread of protein folding problems throughout the cell. Overall, it emerges that adaptive responses, although triggered by stress in one compartment, engage a combination of functional modules for comprehensive cell protection across compartment boundaries.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\     Designation                                        Source or\                        Identifiers                                                                       Additional\
  or resource                                                                    reference                                                                                                           information
  --------------------------- -------------------------------------------------- --------------------------------- --------------------------------------------------------------------------------- -----------------------------------------------------------------------
  Strain (S. cerevisiae)      W303                                               other                                                                                                               see [Supplementary file 3](#supp3){ref-type="supplementary-material"}

  Genetic reagent (E. coli)   *S. cerevisiae* genomic library in YEp13 E. coli   [@bib55]                          ATCC 37323                                                                        

  Antibody                    rat monoclonal anti-HA (clone 3F10)                Roche                             Cat\#11867423001; RRID: [AB_390918](https://scicrunch.org/resolver/AB_390918)     (1:5000)

  Antibody                    rabbit polyclonal anti-mCherry                     Biovision                         Cat\#5993; RRID: [AB_1975001](https://scicrunch.org/resolver/AB_1975001)          (1:5000)

  Antibody                    rabbit polyclonal anti-Kar2                        [@bib68]                                                                                                            (1:50000)

  Antibody                    mouse monoclonal anti-Pgk1 (clone 22C5)            Abcam                             Cat\#Ab113687; RRID: [AB_10861977](https://scicrunch.org/resolver/AB_10861977)    (1:50000)

  Antibody                    goat anti-mouse HRP                                Thermo Fisher Scientific Pierce   Cat\#31432; RRID: [AB_228302](https://scicrunch.org/resolver/AB_228302)           (1:10000)

  Antibody                    goat anti-rabbit HRP                               Thermo Fisher Scientific Pierce   Cat\#31462; RRID: [AB_228338](https://scicrunch.org/resolver/AB_228338)           (1:10000)

  Antibody                    donkey anti-rat HRP                                Jackson                           Cat\#712-035-153; RRID: [AB_2340639](https://scicrunch.org/resolver/AB_2340639)   (1:10000)

  Recombinant DNA reagent     plasmids                                           other                             doi:[10.5061/dryad.n20d476](http://doi.org/10.5061/dryad.n20d476)                 see [Supplementary file 1](#supp1){ref-type="supplementary-material"}

  Commercial assay or kit     NEBuilder HiFi DNA assembly master mix             New England Biolabs               Cat\#E2611L                                                                       

  Commercial assay or kit     BCA assay kit                                      Thermo Fisher Scientific Pierce   Cat\#23225                                                                        

  Commercial assay or kit     ProtoScript II cDNA Synthesis kit                  New England Biolabs               Cat\#E6560L                                                                       

  Commercial assay or kit     SensiFAST SYBR No-ROX kit                          Bioline                           Cat\#BIO-98050                                                                    

  Chemical compound, drug     ß-estradiol                                        Sigma-Aldrich                     Cat\#E8875; CAS: 50-28-2                                                          

  Chemical compound, drug     1NM-PP1                                            Merck                             Cat\#529581--1 MG; CAS: 221244-14-0                                               

  Chemical compound, drug     tunicamycin                                        Merck                             Cat\#654380--50 MG; CAS: 11089-65-9                                               

  Chemical compound, drug     cycloheximide                                      Sigma-Aldrich                     Cat\#C7698; CAS: 66-81-9                                                          

  Chemical compound, drug     complete protease inhibitor                        Roche                             Cat\#04693116001                                                                  

  Software, algorithm         Growthcurver                                       [@bib72]                                                                                                            

  Software, algorithm         MaxQuant                                           [@bib13]                                                                                                            

  Software, algorithm         Perseus                                            [@bib78]                                                                                                            

  Other                       CMAC stain                                         Thermo Fisher Scientific          Cat\#C2110                                                                        

  Other                       mass spectrometry proteomics data                  this study                        PRIDE database, PXD012867                                                         
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmids {#s4-1}
--------

Plasmids are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Sequences of oligonucleotides for plasmid generation are given in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. To generate plasmids for estradiol-inducible expression, P~GAL1~-T~CYC~ was amplified from pRS416-P~GAL1~ ([@bib54]) with primers up_SacI_GAL/CYC_KpnI_down and cloned into AgeI-linearized pRS306-P~ADH1~-GEM or ApaI-linearized pNH605-P~ADH1~-GEM ([@bib63]) by ligation with the NEBuilder HiFi DNA assembly master mix (New England Biolabs, Ipswitch, Massachusetts), yielding pRS306-P~ADH1~-GEM-P~GAL1~ and pNH605-P~ADH1~-GEM-P~GAL1~. Plasmids for expression of HA-tagged CPY\* variants were subsequently generated by amplification of ngCPY\*-HA or CPY\*-HA from pRS315-P~CPY~-ngCPY\*-HA or pRS315-P~GAL1~-CPY\*-HA ([@bib70]) with primers EDY\*\_F2/EDY\*\_R and ligation with SmaI-linearized pRS306-P~ADH1~-GEM-P~GAL1~, yielding pRS306-P~ADH1~-GEM-P~GAL1~-ngCPY\*-HA and pRS306-P~ADH1~-GEM-P~GAL1~-CPY\*-HA. Plasmids for expression of sfGFP-tagged CPY\* variants were generated as follows: FLAG-sfGFP was amplified from pRS305-P~ADH1~-Rtn1-FLAG-sfGFP ([@bib75]) with primers FLAG-sfGFP_F/FLAG-sfGFP_R and ligated with SmaI-linearized pNH605-P~ADH1~-GEM-P~GAL1~, yielding pNH605-P~ADH1~-GEM-P~GAL1~-FLAG-sfGFP. Next, ngCPY\*-HA was amplified from pRS315-P~CPY~-ngCPY\*-HA with primers EDY\*\_F2/EDY\*\_tag_R and ligated into pNH605-P~ADH1~-GEM-P~GAL1~-FLAG-sfGFP linearized with primers FLAG for 1/FLAG-open_R, yielding pNH605-P~ADH1~-GEM-P~GAL1~-ngCPY\*-HA-sfGFP. Similarly, CPY\*(N479Q)-HA was amplified from pRS305-P~CPY~-CPY\*(N479Q)-HA with primers EDY\*\_F2/EDY\*\_tag_R and ligated into pNH605-P~ADH1~-GEM-P~GAL1~-FLAG-sfGFP linearized with primers FLAG for 1/FLAG-open_R, yielding pNH605-P~ADH1~-GEM-P~GAL1~-CPY\*(N479Q)-HA-sfGFP. To subclone genes of interest into YEp13, their coding regions together with upstream and downstream sequences were amplified from yeast genomic DNA with primers providing homologous ends ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). The upstream and downstream sequences encompassed the entire sequence between the coding region of interest and the next upstream and downstream coding region, or at least 400 bp of upstream and 200 bp of downstream sequence. The resulting PCR products were recombined with BamHI-linearized YEp13 through gap repair cloning in yeast. To generate pRS306-P~ADH1~-GEM-P~GAL1~-∆ss-ngCPY\*-HA, pRS306-P~ADH1~-GEM-P~GAL1~-ngCPY\*-HA was linearized by PCR with primers CPY deltaSS fw/CPY deltaSS rev and religated with the NEBuilder HiFi DNA assembly master mix, thereby eliminating the CPY signal sequence. To generate pRS304-HAC1-splicing-reporter, P~HAC1~-Hac1-splicing reporter was amplified from pRS305-HAC1-splicing-reporter with primers pRS304-Eco-Hac1-SR fw/pRS304-Eco-Hac1-SR rev II and ligated with EcoRI-linearized pRS304 ([@bib69]) using the NEBuilder HiFi DNA assembly master mix. To generate pNH604-P~HSP12~-GFP, P~HSP12~-GFP was excised from pNH605-P~HSP12~-GFP with PspOMI/SacII and cloned into the PspOMI/SacII site of pNH604-4xP~HSE~-YFP. To generate pNH605-P~RPN4~-mNeonGreen, mNeonGreen was amplified from pFA6a-mNeonGreen-kanMX4 with primers Xho-neon/neon-BamHI and cloned between the XhoI and BamHI sites of pNH605-P~RPN4~-YFP. Similarly, pNH605-P~RPN4~-(HSEm)-mNeonGreen and pNH605-P~RPN4~-(PDREm)-mNeonGreen were generated by replacing YFP in pNH605-P~RPN4~-(HSEm)-YFP and pNH605-P~RPN4~-(PDREm)-YFP with mNeonGreen. To generate pNH605-P~RPN4~-(YREm)-mNeonGreen and pNH605-P~RPN4~-(YREm,HSEm)-mNeonGreen, pNH605-P~RPN4~-mNeonGreen or pNH605-P~RPN4~-(HSEm)-mNeonGreen were linearized with primers NheI-YRE fw/NheI-YRE rev, digested with NheI and religated, thereby mutating the YRE to an NheI site.

Yeast strain generation {#s4-2}
-----------------------

Strains used in this study are listed in [Supplementary file 3](#supp3){ref-type="supplementary-material"}. Unless indicated otherwise, strains were derived from W303 mating type a (strain SSY122). Gene tagging, gene deletion and promoter replacement was done with PCR products with homologous ends ([@bib48]; [@bib37]). For irreversible single-copy genomic integration of CPY\* expression plasmids, the P~ADH1~-GEM-P~GAL1~ expression cassette was amplified with primers knock-in URA3 fw/knock-in URA3 rev ([Supplementary file 2](#supp2){ref-type="supplementary-material"}) and integrated into the *URA3* locus. For integration of *TRP1*-marked pRS304-HAC1-SR into the *LEU2* locus, the HAC1-splicing-reporter-TRP1 expression cassette was amplified with primers knock-in LEU2 fw/knock-in LEU2 rev ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Other integrative plasmids were linearized by restriction digest before transformation.

Growth conditions {#s4-3}
-----------------

Strains were cultured at 30°C in SCD medium consisting of 0.7% yeast nitrogen base, 2% glucose and amino acids, lacking leucine where appropriate to maintain plasmid selection. *Sec65-1* cells were grown in the same medium at 25°C. For steady state analyses, cultures were grown to saturation, diluted and grown for at least 9 hr so that they reached mid log phase (OD~600~ = 0.5--1). For induction of CPY\* expression, exponentially growing cells were diluted to early log phase (OD~600~ = 0.1--0.5) and treated with 50 nM β-estradiol (Sigma-Aldrich, St. Louis, Missouri) for 4 hr, unless indicated otherwise. For cycloheximide chase experiments, cells in mid log phase were treated with 50 µg/ml cycloheximide (Sigma-Aldrich). For tunicamycin treatment, exponentially growing cells were diluted to early log phase and treated with 2 or 5 µg/ml tunicamycin (Merck, Darmstadt, Germany) as indicated. For 1NM-PP1 treatment, exponentially growing cells were diluted to early log phase and treated with 3 µM 1NM-PP1 (Merck). For temperature shift experiments, cells grown to mid log phase at 25°C were diluted to OD~600~ = 0.2 and incubated at the indicated temperatures for 90 min.

*HAC1* splicing, *HSE*, *HSP12* and *RPN4* reporter assays {#s4-4}
----------------------------------------------------------

To measure UPR activity, a *HAC1* splicing reporter was used that translates Ire1 activity into the production of GFP ([@bib62]). To measure induction of the UPR, cells harboring this reporter were grown to mid log phase in 1 ml medium in 96 deep-well plates. Cells were diluted to early log phase, treated with estradiol or tunicamycin as described above, 100 µl aliquots were removed at each time point and GFP fluorescence after excitation with a 488 nm laser was measured with a FACS Canto flow cytometer (BD Biosciences, Franklin Lakes, New Jersey) equipped with a high-throughput sampler. In parallel, autofluorescence was determined with identically grown isogenic control strains not harboring the splicing reporter. Mean cellular GFP fluorescence was corrected for autofluorescence and normalized to the GFP fluorescence of untreated cells. To measure steady state UPR activity in different strains, cells expressing the *HAC1* splicing reporter and cytosolic BFP under the control of the constitutive *GPD* promoter were grown to mid log phase as above and GFP and BFP fluorescence were measured after excitation with 488 nm or 405 nm lasers. GFP fluorescence was corrected for autofluorescence and divided by BFP fluorescence to account for differences in protein translation capacity. Data were expressed relative to the GFP/BFP fluorescence ratio in wild-type cells.

To measure Hsf1 and Msn2/4 activity, cells harboring the 4xHSE-YFP or the HSP12-GFP reporter and expressing ngCPY\* under the control of the estradiol-inducible *GAL* promoter system were grown to mid log phase as above and diluted to early log phase. Cells were either left untreated or were treated with 100 nM estradiol for 5 hr, 100 µl aliquots were removed and GFP fluorescence was measured. GFP fluorescence was corrected for autofluorescence and corrected fluorescence of treated cells was normalized to that of corresponding untreated cells.

To measure Rpn4 activity, cells harboring an *RPN4* reporter and expressing cytosolic BFP under the control of the constitutive *GPD* promoter were grown to mid log phase as above. To measure steady state *RPN4* activity, 100 µl aliquots were removed and mNeonGreen and BFP fluorescence was measured after excitation with 488 nm or 405 nm lasers as above. Mean cellular mNeonGreen fluorescence was corrected for autofluorescence as above and divided by BFP fluorescence. Data were expressed relative to the mNeonGreen/BFP fluorescence ratio in cells harboring the wild-type *RPN4* reporter. To measure induction of *RPN4*, cells were grown to mid log phase as above, diluted to early log phase and either left untreated or were treated with 5 µg/ml tunicamycin or 3 µM 1NM-PP1. At each time point, 100 µl aliquots were removed and mNeonGreen and BFP fluorescence was determined. For each time point, autofluorescence-corrected mNeonGreen/BFP ratios were calculated as above and ratios in treated cells were normalized to those in corresponding untreated cells.

Western blotting {#s4-5}
----------------

Cell lysis and western blotting was done as described ([@bib75]). In brief, cells were disrupted by bead beating, proteins were solubilized with SDS, protein determination was carried out with the BCA assay kit (Thermo Fisher Scientific Pierce, Waltham, Massachusetts), equal amounts of protein were resolved by SDS-PAGE and transferred onto nitrocellulose membranes. Membranes were probed with primary and HRP-coupled secondary antibodies, developed with homemade ECL, and chemiluminescence was detected with an ImageQuant LAS 4000 imaging system (GE Healthcare, Chalfont St Giles, UK). Images were quantified with ImageJ and processed with Adobe Photoshop. Primary antibodies were rat anti-HA 3F10 (Roche, Basel, Switzerland), rabbit anti-Kar2 (Peter Walter, UCSF), rabbit anti-mCherry (Biovision, Milpitas, California) and mouse anti-Pgk1 22C5 (Abcam, Cambridge, UK).

Light microscopy {#s4-6}
----------------

CPY\* expression was induced with 25 nM estradiol for 4 hr. Ten µM CMAC (Thermo Fisher Scientific, Waltham, Massachusetts) was added during the last 2 hr of induction to stain the vacuole and cells were imaged live at room temperature. Images were acquired with a DMi8 inverted microscope (Leica, Wetzlar, Germany) equipped with a CSU-X1 spinning-disk confocal scanning unit (Yokogawa, Musashino, Japan), a ORCA-Flash 4.0 LT camera (Hamamatsu, Hamamatsu, Japan) and a HC PL APO 100x/1.4 NA CS2 oil objective lens (Leica). Background subtraction with a rolling ball algorithm was performed in ImageJ and images were processed in Adobe Photoshop.

Growth assays {#s4-7}
-------------

Growth assays on agar plates and in liquid medium were done as described ([@bib68]; [@bib75]). For growth assays on agar plates, dilution series with fivefold dilution steps were used. For quantification of growth in liquid medium, the cell density in arbitrary units was plotted against time and the area under the curve was calculated with the R package Growthcurver ([@bib72]). Data were normalized to the wild-type control and expressed as a growth index, which was set to one for wild-type cells.

Viability assay {#s4-8}
---------------

Exponentially growing cells were diluted to OD~600~ = 0.05 and grown in the presence of different concentrations of β-estradiol for 24 hr. Cultures were diluted to equal cell densities as judged by OD~600~ measurements, equal numbers of cells were plated on solid YPD medium (1% yeast extract, 2% peptone, 2% glucose) and grown for 48 hr. To determine cell viability, the number of colony-forming units of estradiol-treated samples was normalized that of the mock-treated sample.

Genetic screen {#s4-9}
--------------

Strain SSY1341 was transformed with a yeast genomic library in the YEp13 multicopy vector ([@bib55]; available from the American Type Culture Collection as ATCC 37323; kindly provided by Michael Knop, ZMBH). Transformants were plated onto SCD-Leu plates at approximately 200 colony-forming units per plate and grown at 30°C. After 26 hr, colonies were replicated onto SCD-Leu plates containing 50, 75 or 100 nM estradiol and grown for up to 36 hr. Colonies that clearly grew better than the general background were restreaked onto SCD-Leu plates and replicated onto SCD-inositol to identify transformants that grew due to re-expression of *HAC1*. For confirmation, plasmids were retrieved from six transformants that grew in the absence of inositol and sequenced with primers YEp13 fw/YEp13 rev ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). All contained *HAC1*. Transformants that failed to grow without inositol and hence lacked *HAC1* were re-tested by growth assays on SCD-Leu plates containing 50 nM estradiol. Suppressing plasmids were retrieved from well-growing transformants and their inserts were sequenced. Inserts contained between one and six genes. To determine which genes were responsible for suppression, candidates were individually subcloned into YEp13 from genomic DNA from SSY122 and tested for growth on SCD-Leu plates containing 50 nM estradiol. Genes identified only once were discarded, with the exception of *PDR1* and *YAP1*.

Quantitative real-time PCR {#s4-10}
--------------------------

Isolation of mRNA, cDNA synthesis and quantitative real-time PCR were done as described ([@bib75]). In brief, RNA from 5 ODs of cells was extracted with hot phenol, precipitated with ethanol and resuspended in 30 µl H~2~O. Synthesis of cDNA was done from 0.5 µg total RNA with the Protoscript II kit (New England Biolabs) using d(T)~18~ primers. PCRs containing 5 ng template DNA and 250 nM each of forward and reverse primers were prepared using the SensiFAST SYBR No-ROX kit (Bioline, Luckenwalde, Germany). Primer sequences are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. PCRs were run in triplicate on a LightCylcer II 480 (Roche) with an annealing temperature of 60°C and an extension time of 20 s. The *TAF10* mRNA served as internal standard to determine relative mRNA levels of *KAR2*, *SIL1* or *RPN4*. Data analysis was performed with the LightCylcer II 480 software using the 2^nd^ derivative maximum method to determine Cp (crossing point) values.

Proteomics {#s4-11}
----------

Wild-type (SSY122) and *∆rpn4* (SSY784) cells were grown to mid-log phase in SCD medium. Cultures were diluted to OD 0.4, and 5 ODs of cells were harvested as untreated samples. Tunicamycin was added to the remainder of each culture at a final concentration of 5 µg/ml, cells were grown for 4 hr, and 5 ODs of cells were harvested as treated samples. Cells were collected by centrifugation and snap frozen in liquid nitrogen. Samples from four independent experiments were used for proteomic analysis. Cells were resuspended in ice-cold lysis buffer (50 mM Tris, pH 7.5, 0.5 mM EDTA, 1x Roche complete protease inhibitors) and disrupted by bead beating. Proteins were solubilized by adding SDS to a final concentration of 1.8% (w/v) and heating to 95°C for 10 min. Protein concentrations were determined with a BCA assay kit (Thermo Fisher Scientific). Per sample, 200 µg protein was precipitated with acetone and resuspended in digestion buffer (8 M Urea, 50 mM Tris pH 8.5, 1 mM DTT) to a concentration of 4 mg/ml. 40 µg protein was alkylated using 5 mM iodoacetamide for 1 hr, digested with LysC (enzyme to protein = 1:50 (w/w)) for 5.5 hr, diluted to 2 M Urea, and digested with Trypsin (1:50 (w/w)) for another 13 hr at room temperature. Digested peptides were acidified to 1% (v/v) trifluoroacetic acid, cleared of precipitates by brief centrifugation, desalted via SDB-RPS cleanup, and analyzed on a Q Exactive HF-X Hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific), essentially as described ([@bib36]). Raw files were processed using MaxQuant ([@bib14]) version 1.6, using the MaxLFQ algorithm ([@bib13]) for label free-quantification. Downstream analysis was performed in Perseus version 1.6 ([@bib78]). LFQ intensities based on fewer than 2 MS/MS counts were removed from the dataset. The remaining intensities were log-transformed. For the pairwise analyses in [Figures 4D](#fig4){ref-type="fig"} and [5F](#fig5){ref-type="fig"}, further quality filtering was applied. Only proteins that were quantified in all four replicates of at least one of the compared conditions were retained. Missing values were then imputed from a normal distribution (width 0.3 SDs, down-shifted by 1.8 SDs). For statistical analysis, a two-sided student's t-test with permutation based false discovery rate control (FDR = 1%) and an S0 parameter of 0.2 was performed. The category annotation enrichment was calculated with the 1D annotation enrichment tool in Perseus ([@bib78]), using mean log~2~ expression differences. For the analysis in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}, only proteins annotated as 'proteasome subunit' and with at least three quantified intensities in each condition were included. For each protein, the median value of the untreated wild-type sample was subtracted from the median intensities in all conditions, to achieve normalization. The resulting values correspond to log~2~ fold changes relative to the untreated wild-type (which has a value of 0). The mean and standard error of the mean were plotted. Proteasome subunits were defined as the 33 structural proteins of the 20S core particle and the 19S regulatory particle ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). All were detected consistently, except for Sem1. Core UPR target genes were defined as those identified as UPR-regulated by both [@bib77] and [@bib63] ([Supplementary file 5](#supp5){ref-type="supplementary-material"}). Of the corresponding 102 proteins, 69 were detected in total, and 50 and 58 passed the quality filters for the analyses in [Figures 4D](#fig4){ref-type="fig"} and [5F](#fig5){ref-type="fig"}, respectively. See [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"} for assignment of proteins to other functional groups.

Experimental design {#s4-12}
-------------------

Control strains were isogenic to the experimental strains except for the relevant genetic modifications. For experiments with *sec65-1* cells, strain SSY002 (W303 mating type alpha) rather than SSY122 was used as a control because it has the same mating type and also is an *ade2* mutant. At least three biological replicates were done for experiments with quantitative read-outs to enable assessment of the variation between replicates. Exceptions were the experiments in [Figure 1E](#fig1){ref-type="fig"}, [Figure 1F](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, which were done only once. Repetitions were considered biological replicates if they were initiated from independently inoculated pre-cultures of the yeast strains used and were performed on different days. For each experiment, the number of biological replicates (n), the mean and the standard error of the mean (SEM) are reported in the figure legends.

Data availability {#s4-13}
-----------------

The mass spectrometry proteomics data associated with [Figure 4D](#fig4){ref-type="fig"}, [Figure 5F](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD012867.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"The proteasome biogenesis regulator Rpn4 cooperates with the unfolded protein response to promote ER stress resistance\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Anna Akhmanova as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal his identity: David Pincus (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

In this manuscript, the authors use a titratable ER stress inducing system in yeast to identify specific stress-responsive pathways that coordinate with the UPR to protect cells against ER stress. In a suppressor screen, they show that overexpression of *RPN4* (and many other genes known to regulate *RPN4*) rescues growth defects in yeast deficient in the UPR-associated transcription factor treated with different types of ER stress. *RPN4* is the yeast transcription factor primarily responsible for regulating proteasome activity. They go on to show that *rpn-4* and *hac-1* synthetically influence yeast growth in the absence and presence of stress, suggesting cooperative protective activities for these transcription factors. In response to ER stress, the authors propose that impaired ERAD and the accumulation of mislocalized ER proteins in the cytosol challenge proteasome activity resulting in *RPN4* activation. Initially, *RPN4* is post-transcriptionally regulated, likely through impaired proteasomal degradation, but at later points, *rpn-4* is transcriptionally induced in a process dependent on multiple stress-responsive transcription factors including *HSF1* and *YAP*. Ultimately, the authors propose that *RPN4* and *HAC1* represent two complementary signaling mechanisms involved in coordinating the cellular response in response to ER stress.

Overall, this is an interesting manuscript addressing important questions related to the coordination of stress-pathways in response to diverse insults. The experiments are generally well performed and the conclusions are supported by the experimental data. However, we have identified three points that we feel must be addressed in revision and also ask you to consider (at your discretion) other points that came up in review, provided they can may be addressed in short order.

Essential revisions:

1\) Drawing on point 1 of reviewer 1 and 2 we note that the genetic link to Rpn4 is a key conclusion of the paper. As you speculate that some of the other hit in the high-dose suppressor screen may encode genes that operate upstream of Rpn4, we think it is reasonable to ask that you apply genetic tests to examine this point.

2\) Drawing on point 2 of reviewers 1 and 2, and also referred to by reviewer 3, we feel that the question whether Rpn4 upregulation impacts favourably on the well-being of ER stressed cells by helping restore protein folding homeostasis in the ER or by some other mechanism is a key element of the paper. Therefore, we ask that you try to address this point further. Whether you do so by measuring the level of *IRE1* activity (with a splicing reporter) or by directly measuring the buildup of unfolded proteins, or by some other more clever means, will be up to you.

3\) Drawing on point 4 of reviewers 2 and the comments of reviewer 3, we ask that you extend the analysis beyond Rpn4 and examine the effects of unmitigated ER stress on expression of proteasome subunits and other genes in the proteasome biogenesis sphere.

*Reviewer \#1:*

This paper presents a thorough analysis of the interactions between protein quality control pathways in the yeast ER and cytosol. The key insights have been gleaned from application of an unbiased technique: a genomic high dose suppressor library. This genome wide screen revealed the capacity for enhanced expression of Rpn4 (a transcription factor concerned with activation of genes important for proteasomal biogenesis) and potentially allied genes, to buffer the consequence of deficiencies in the UPR in ER-stressed yeast.

The findings here give rise to some interesting, unanticipated conclusions. Notably that the aforementioned buffering occurs despite the fact that the transcriptional control of genes that enhance the protein folding capacity of the ER and the genes involved in proteasome biogenesis occurs by parallel pathways.

There two points of critique that I feel should be addressed:

The authors present a strong case that in the unbuffered state (e.g. tunicamycin-treated ∆*hac1* yeast) activation of Rnp4 arises by the presence in the cytosol of proteins that would otherwise find their way into the ER. This begs the question if the buffering of the growth defect arising from Rnp4 over-expression reflects predominantly the role of the proteasome in alleviating this cytosolic problem, or if the presumptive enhanced proteasomal function of Rpn4(+) cells also reflects a cross compartment effect, whereby the Rpn4(+); E2-treated ngCPY\*; ∆*hac1* cells also experience lower levels of ER stress; lower than the comparison group in which Rpn4 is not over-expressed? It may be possible to gage the level of unfolded protein stress in the ER by monitoring the state of Ire1p activity. I\'m not sure if it is possible to monitor endogenous Ire1p phosphorylation in budding yeast, but perhaps this question can be answered by introducing an inert Hac1 splicing reporter into the experimental system.

The authors speculate on the possibility that buffering observed by Pdr1 and Ssz1 over-expression may be channelled through their role in raising the levels of Rpn4, thus providing a unifying mechanism of action for the top hits in this screen. Can this notion be tested? Is the buffering by Pdr1(+) and Ssz1(+) of E2-treated ngCPY\*; ∆*hac1* cells eliminated by ∆Rpn4?

*Reviewer \#2:*

In this manuscript, the authors use a titratable ER stress inducing system in yeast to identify specific stress-responsive pathways that coordinate with the UPR to protect cells against ER stress. In a suppressor screen, they show that overexpression of *RPN4* (and many other genes known to regulate *RPN4*) rescues growth defects in yeast deficient in the UPR-associated transcription factor treated with different types of ER stress. *RPN4* is the yeast transcription primarily responsible for regulating proteasome activity. They go on to show that *rpn-4* and *hac-1* synthetically influence yeast growth in the absence and presence of stress, suggesting cooperative protective activities for these transcription factors. In response to ER stress, the authors propose that impaired ERAD and the accumulation of mislocalized ER proteins in the cytosol challenge proteasome activity resulting in RPN4 activation. Initially, *RPN4* is post-transcriptionally regulated, likely through impaired proteasomal degradation, but at later points, *rpn*-4 is transcriptionally induced in a process dependent on multiple stress-responsive transcription factors including *HSF1* and *YAP*. Ultimately, the authors propose that *RPN4* and *HAC1* represent two complementary signaling mechanisms involved in coordinating the cellular response in response to ER stress.

Overall, this is an interesting manuscript addressing important questions related to the coordination of stress-pathways in response to diverse insults. The experiments are generally well performed and the conclusions are supported by the experiments. However, I have a few specific comments primarily pertaining the relationship between *RPN4* activation and specific biologic functions during ER stress that should be addressed prior to publication. I outline these comments below.

1\) The authors suggest that other genes identified in their screen (e.g., *PDR1, SSZ1*, and *YAP1*) promote cellular growth of *hac1*-deficient cells in the presence of ER stress through activation of *RPN4*. If this is the case, one would predict that overexpression of these genes would not rescue growth in *rpn4*-deficient yeast incubated with increasing amounts of ER stress. This would provide further evidence that these genes function in the screen through the upregulation of *RPN4*, as suggested. Alternatively, this could function through alternative mechanisms. Either way, it would be interesting to define the specific dependence of gene rescue from these different hits on *RPN-4*.

2\) The authors suggest that the increased UPR afforded by ER stress in *rpn-4* deficient yeast results from the ER buildup of misfolded ERAD substrates. This is probably true, but it would be good to see the increased ER accumulation of these proteins to confirm this model.

3\) The authors suggest that accumulation of ER proteins through either increased ERAD or impaired translocation is responsible for the increased *RPN4* activity observed during ER stress. They do a nice job of testing the impaired translocation using the *sec65* mutant. However, it would be interesting to define the importance of ERAD in this process using *hrd-1* deficient yeast. If ERAD is required, one would expect that overexpression of *RPN4* should not rescue growth under these conditions. It would be nice to complete the study by testing this alternative mechanism of increased cytosolic protein load afforded by increased ERAD.

4\) The idea is that increases in *RPN4* coordinate with the UPR by upregulating proteasome biogenesis (i.e., increasing proteasome capacity). However, increased expression of proteasome subunits and measures of proteasome activity are not provided (although they do show modest increases in the degradation of cytosolic proteins in cells following *RPN4* overexpression). If *RPN4* is protective during ER stress through increased proteasome biogenesis, shouldn\'t there be a measurable increase in proteasome capacity? Also, shouldn\'t there be an increase in proteasome subunit expression? This type of information should be provided to support the overall model proposed in panel 7F.

5\) Along the same lines as \#3, does ER stress induce proteasome biogenesis in mammalian cells? There are lots of transcriptional profiles available, and it would be interesting to see if this model is conserved in higher eukaryotes. If not, are there other mechanisms involved that perform a similar function such as the iRHom regulation during ER stress in flies reported by Lee et al., 2015?

6\) The authors show that they can suppress the transcriptional upregulation of *RPN4* by deletion of *MSN2/4* and removal of the YRE and HSE from the *rpn-4* promoter. Can they use this approach to define the relative importance of posttranscriptional and transcriptional regulation of *RPN4* during ER stress? It would be interesting to define the specific dependence of yeast protection against ER stress on these two aspects of *RPN4* regulation.

*Reviewer \#3:*

This paper by Schmidt and Schuck is a valuable contribution to our understanding of cellular stress response signaling. The major conclusion is that the accumulation of unfolded proteins in the lumen of the ER does not merely activate the UPR(er), but rather triggers a chain of events that results in mistargeting of ER clients to the cytosol where they trigger a secondary set of proteostasis pathways. These pathways converge on the transcription of *RPN4*, which encodes the master transcriptional regulator of proteasome biogenesis, thereby promoting protein degradation. The experiments are well executed and clearly presented in the text and figures, and the data are convincing.

To arrive at their conclusions, the authors develop a titratable induction system in yeast that allows them to tune the level of unfolded proteins in the ER, and they couple it to fluorescent reporters that allow them to measure activity in the UPR and other stress response pathways. In my opinion, this system now represents the gold standard for physiological/homeostatic probing of the UPR and should be refactored and ported to mammalian cells. They also nicely connected the dots between ER stress and overload to cytosolic mistargeting using a Kar2-SS cleavage assay and a *sec65*-ts mutant.

The only aspect of the paper that is wanting is the end, where the authors bash the *RPN4* promoter and use analog sensitive PKA and *msn2/4*∆ strains to attempt to define the signals that activate *RPN4*. The approach here is a bit muddled and as such the conclusion is not clear. To bring this home, I would recommend doing a clean necessary/sufficient scan of the TF binding sites in the *RPN4* promoter. Start with 1kb upstream of *RPN4*: there are 6 STREs, 2 PDREs, 1 YRE and 1 HSE (I am happy to send my analysis of where the STREs are, as apparently the authors could not find them). In addition to the PDRE, YRE and HSE mutants the authors have, order a GBlock lacking the STREs and do the RT-qPCR. This will complete the necessity set. For sufficiency, just order 4 Gblocks that have only the 6 STREs, 2PDREs, the YRE or the HSE. Then add Tm and induced ngCPY\* and measure *RPN4* expression and growth in this set. The PKA/*msn2/4* mutants, while clever, don\'t make the point as clearly.

10.7554/eLife.43244.028

Author response

> Essential revisions:
>
> 1\) Drawing on point 1 of reviewer 1 and 2 we note that the genetic link to Rpn4 is a key conclusion of the paper. As you speculate that some of the other hit in the high-dose suppressor screen may encode genes that operate upstream of Rpn4, we think it is reasonable to ask that you apply genetic tests to examine this point.

We clarified this point by generating strains in which the *RPN4* gene was placed under the control of the constitutive *CYC1* promoter and thus uncoupled from its normal regulation. Overexpression of *PDR1, SSZ1* or *YAP1* still promoted ER stress resistance in this background. Therefore, Pdr1, Ssz1 and Yap1 can act through mechanisms unrelated to *RPN4* gene activation (subsection "A screen for genes promoting ER stress resistance in UPR mutants", second paragraph and new Figure 3A). We also tried to do similar experiments in *∆hac1 ∆rpn4* cells but their extremely poor growth even in the absence of exogenous ER stressors (see Figure 3B and 3C) rendered these attempts uninformative.

> 2\) Drawing on point 2 of reviewers 1 and 2, and also referred to by reviewer 3, we feel that the question whether Rpn4 upregulation impacts favourably on the well-being of ER stressed cells by helping restore protein folding homeostasis in the ER or by some other mechanism is a key element of the paper. Therefore, we ask that you try to address this point further. Whether you do so by measuring the level of IRE1 activity (with a splicing reporter) or by directly measuring the build-up of unfolded proteins, or by some other more clever means, will be up to you.

Using reporters for the activity of Ire1, Hsf1 and the stress response transcription factors Msn2/4, we now show that *RPN4* overexpression can improve protein folding homeostasis in both the ER and the cytosol of ER-stressed cells (subsection "Rpn4 is upregulated by and protects against mislocalized secretory proteins", last paragraph and new Figure 7E). This finding supports the proposed cross-compartment response to ER stress.

> 3\) Drawing on point 4 of reviewers 2 and the comments of reviewer 3, we ask that you extend the analysis beyond Rpn4 and examine the effects of unmitigated ER stress on expression of proteasome subunits and other genes in the proteasome biogenesis sphere.

To address this point, we performed proteomic analyses of untreated and tunicamycin-treated wild-type and *∆rpn4* cells. As anticipated from the activation of Rpn4 by ER stress, the expression levels of proteasome subunits and proteasome assembly chaperones rose in tunicamycin-treated wild-type cells (subsection "Rpn4 and the UPR cooperate to counteract ER stress", last paragraph and new Figure 5F). A comparison of wild-type and *∆rpn4* cells at steady state showed a reduction in proteasome subunit abundance and chronic UPR activation, as expected. Furthermore, we observed that untreated *∆rpn4* cells accumulate proteins normally degraded by ERAD, upregulate proteasome assembly factors, mount a constitutive heat shock response and attenuate ribosome biogenesis, illustrating a broad adaptive response (see the second paragraph of the aforementioned subsection and new Figure 4D). Finally, we found that, surprisingly, *∆rpn4* cells still elevate proteasome subunit abundance during ER stress (subsection "Rpn4 and the UPR cooperate to counteract ER stress", last paragraph and new Figure 5---figure supplement 2). However, this response is insufficient to reach the levels seen in wild-type cells.

Reviewer \#1:

\[...\] There two points of critique that I feel should be addressed:

> The authors present a strong case that in the unbuffered state (e.g. tunicamycin-treated ∆hac1 yeast) activation of Rnp4 arises by the presence in the cytosol of proteins that would otherwise find their way into the ER. This begs the question if the buffering of the growth defect arising from Rnp4 over-expression reflects predominantly the role of the proteasome in alleviating this cytosolic problem, or if the presumptive enhanced proteasomal function of Rpn4(+) cells also reflects a cross compartment effect, whereby the Rpn4(+); E2-treated ngCPY\*; ∆hac1 cells also experience lower levels of ER stress; lower than the comparison group in which Rpn4 is not over-expressed? It may be possible to gage the level of unfolded protein stress in the ER by monitoring the state of Ire1p activity. I\'m not sure if it is possible to monitor endogenous Ire1p phosphorylation in budding yeast, but perhaps this question can be answered by introducing an inert Hac1 splicing reporter into the experimental system.

Using reporters for the activity of Ire1, Hsf1 and the stress response transcription factors Msn2/4, we now show that *RPN4* overexpression can improve protein folding homeostasis in both the ER and the cytosol of ER-stressed cells (subsection "Rpn4 is upregulated by and protects against mislocalized secretory proteins", last paragraph and new Figure 7E). This finding supports the proposed cross-compartment response to ER stress.

> The authors speculate on the possibility that buffering observed by Pdr1 and Ssz1 over-expression may be channelled through their role in raising the levels of Rpn4, thus providing a unifying mechanism of action for the top hits in this screen. Can this notion be tested? Is the buffering by Pdr1(+) and Ssz1(+) of E2-treated ngCPY\*; ∆hac1 cells eliminated by ∆Rpn4?

We clarified this point by generating strains in which the *RPN4* gene was placed under the control of the constitutive *CYC1* promoter and thus uncoupled from its normal regulation. Overexpression of *PDR1, SSZ1* or *YAP1* still promoted ER stress resistance in this background. Therefore, Pdr1, Ssz1 and Yap1 can act through mechanisms unrelated to *RPN4* gene activation (subsection "A screen for genes promoting ER stress resistance in UPR mutants", second paragraph and new Figure 3A). We also tried to do similar experiments in *∆hac1 ∆rpn4* cells but their extremely poor growth even in the absence of exogenous ER stressors (see Figure 3B and 3C) rendered these attempts uninformative.

Reviewer \#2:

> \[...\] Overall, this is an interesting manuscript addressing important questions related to the coordination of stress-pathways in response to diverse insults. The experiments are generally well performed and the conclusions are supported by the experiments. However, I have a few specific comments primarily pertaining the relationship between RPN4 activation and specific biologic functions during ER stress that should be addressed prior to publication. I outline these comments below.
>
> 1\) The authors suggest that other genes identified in their screen (e.g., PDR1, SSZ1, and YAP1) promote cellular growth of hac1-deficient cells in the presence of ER stress through activation of RPN4. If this is the case, one would predict that overexpression of these genes would not rescue growth in rpn4-deficient yeast incubated with increasing amounts of ER stress. This would provide further evidence that these genes function in the screen through the upregulation of RPN4, as suggested. Alternatively, this could function through alternative mechanisms. Either way, it would be interesting to define the specific dependence of gene rescue from these different hits on RPN-4.

We clarified this point by generating strains in which the *RPN4* gene was placed under the control of the constitutive *CYC1* promoter and thus uncoupled from its normal regulation. Overexpression of *PDR1, SSZ1* or *YAP1* still promoted ER stress resistance in this background. Therefore, Pdr1, Ssz1 and Yap1 can act through mechanisms unrelated to *RPN4* gene activation (subsection "A screen for genes promoting ER stress resistance in UPR mutants", second paragraph and new Figure 3A). We also tried to do similar experiments in *∆hac1 ∆rpn4* cells but their extremely poor growth even in the absence of exogenous ER stressors (see Figure 3B and 3C) rendered these attempts uninformative.

> 2\) The authors suggest that the increased UPR afforded by ER stress in rpn-4 deficient yeast results from the ER buildup of misfolded ERAD substrates. This is probably true, but it would be good to see the increased ER accumulation of these proteins to confirm this model.

As part of our proteomic analyses (see point 4 below), we found that deletion of *RPN4* increases the abundance of several proteins that are involved in sterol synthesis and constitutively turned over by different ERAD pathways (subsection "Rpn4 and the UPR cooperate to counteract ER stress", second paragraph and new Figure 4D). This observation supports the model that lack of Rpn4 activity leads to a buildup of ERAD substrates and subsequent UPR activation. Importantly, the alternative explanation that lack of Rpn4 activity causes UPR activation by a different mechanism and in this way upregulates expression of the above ERAD substrates is unlikely because the genes encoding these ERAD substrates are not regulated by the UPR.

> 3\) The authors suggest that accumulation of ER proteins through either increased ERAD or impaired translocation is responsible for the increased RPN4 activity observed during ER stress. They do a nice job of testing the impaired translocation using the sec65 mutant. However, it would be interesting to define the importance of ERAD in this process using hrd-1 deficient yeast. If ERAD is required, one would expect that overexpression of RPN4 should not rescue growth under these conditions. It would be nice to complete the study by testing this alternative mechanism of increased cytosolic protein load afforded by increased ERAD.

It appears that we misled the reviewer by our inaccurate portrayal of the role of *HRD1* in ERAD. While important, Hrd1 is not 'essential' for ERAD as we had phrased it, because several ERAD pathways exist even in yeast (mediated by the ubiquitin ligases Hrd1, Doa10 and Asi1/2/3). Therefore, the suggested epistasis experiment of completely blocking ERAD and asking whether now *RPN4* overexpression no longer rescues growth is difficult to do and outside the scope of this revision. However, the fundamental point raised by the reviewer remains valid and it will be interesting to determine whether the increased cytosolic protein folding load that activates and is mitigated by Rpn4 arises from impaired translocation, increased ERAD, or both.

We originally included *HAC1* splicing in *∆hrd1* cells merely as a reference point for the *HAC1* splicing seen in *∆rpn4* cells. Since the qPCR data (Figure 4B and C) and proteomics data (new Figure 4D) clearly show constitutive UPR activation in *∆rpn4* cells, we would like to avoid any confusion and have removed *∆hrd1* cells from Figure 4A. The figure's conclusion, i.e. that there is elevated *HAC1* splicing in *rpn4∆* cells, is unaffected by this change.

> 4\) The idea is that increases in RPN4 coordinate with the UPR by upregulating proteasome biogenesis (i.e., increasing proteasome capacity). However, increased expression of proteasome subunits and measures of proteasome activity are not provided (although they do show modest increases in the degradation of cytosolic proteins in cells following RPN4 overexpression). If RPN4 is protective during ER stress through increased proteasome biogenesis, shouldn\'t there be a measurable increase in proteasome capacity? Also, shouldn\'t there be an increase in proteasome subunit expression? This type of information should be provided to support the overall model proposed in panel 7F.

To address this point, we performed proteomic analyses of untreated and tunicamycin-treated wild-type and *∆rpn4* cells. As anticipated from the activation of Rpn4 by ER stress, the expression levels of proteasome subunits and proteasome assembly chaperones rose in tunicamycin-treated wild-type cells (subsection "Rpn4 and the UPR cooperate to counteract ER stress", last paragraph and new Figure 5F). A comparison of wild-type and *∆rpn4* cells at steady state showed a reduction in proteasome subunit abundance and chronic UPR activation, as expected. Furthermore, we observed that untreated *∆rpn4* cells accumulate proteins normally degraded by ERAD, upregulate proteasome assembly factors, mount a constitutive heat shock response and attenuate ribosome biogenesis, illustrating a broad adaptive response (subsection "Rpn4 and the UPR cooperate to counteract ER stress", second paragraph and new Figure 4D). Finally, we found that, surprisingly, *∆rpn4* cells still elevate proteasome subunit abundance during ER stress (subsection "Rpn4 and the UPR cooperate to counteract ER stress", last paragraph, and new Figure 5---figure supplement 2). However, this response is insufficient to reach the levels seen in wild-type cells.

> 5\) Along the same lines as \#3, does ER stress induce proteasome biogenesis in mammalian cells? There are lots of transcriptional profiles available, and it would be interesting to see if this model is conserved in higher eukaryotes. If not, are there other mechanisms involved that perform a similar function such as the iRHom regulation during ER stress in flies reported by Lee et al., 2015?

Prompted by this query and also the comment of reviewer \#1 above, we expanded the section on mammalian cells in the Discussion and included the Lee et al. paper mentioned above (Discussion, fifth paragraph). We use Nrf1 and the iRhom1-regulated PAC1/2 as examples to illustrate how ER stress can induce proteasome biogenesis in mammals. A systematic analysis of transcriptional profiles would certainly be interesting but is outside the scope of this revision.

> 6\) The authors show that they can suppress the transcriptional upregulation of RPN4 by deletion of MSN2/4 and removal of the YRE and HSE from the rpn-4 promoter. Can they use this approach to define the relative importance of posttranscriptional and transcriptional regulation of RPN4 during ER stress? It would be interesting to define the specific dependence of yeast protection against ER stress on these two aspects of RPN4 regulation.

It would indeed be of interest to understand the relative contribution of the post-transcriptional and transcriptional regulation of Rpn4 to ER stress resistance. However, since it remains to be established how Msn2/4 activate the *RPN4* promoter (also see response to the first comment of reviewer \#3 below), the only way currently available to block the transcriptional induction of *RPN4* involves deletion of Msn2/4, which will by itself cause stress sensitivity. Hence, this question cannot be addressed cleanly at this point.

Reviewer \#3:

> \[...\] The only aspect of the paper that is wanting is the end, where the authors bash the RPN4 promoter and use analog sensitive PKA and msn2/4∆ strains to attempt to define the signals that activate RPN4. The approach here is a bit muddled and as such the conclusion is not clear. To bring this home, I would recommend doing a clean necessary/sufficient scan of the TF binding sites in the RPN4 promoter. Start with 1kb upstream of RPN4: there are 6 STREs, 2 PDREs, 1 YRE and 1 HSE (I am happy to send my analysis of where the STREs are, as apparently the authors could not find them). In addition to the PDRE, YRE and HSE mutants the authors have, order a GBlock lacking the STREs and do the RT-qPCR. This will complete the necessity set. For sufficiency, just order 4 Gblocks that have only the 6 STREs, 2PDREs, the YRE or the HSE. Then add Tm and induced ngCPY\* and measure RPN4 expression and growth in this set. The PKA/msn2/4 mutants, while clever, don\'t make the point as clearly.

Direct communication with the reviewer established that there is no canonical STRE in the *RPN4* promoter, so the suggested experiments cannot be done.
